Physician profile
James L Roberts
NPI 1508972191
$5,713.94
in general payments reported to CMS, 2019-2025
49 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $329 · 2021: $744 · 2022: $952 · 2023: $1,029 · 2024: $1,011 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,193.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $419.43 | 2021-2025 | Jelmyto |
| Janssen Biotech, INC. | $319.28 | 2022-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $281.35 | 2019-2025 | |
| Hollister Incorporated | $269.65 | 2021-2023 | Vapro |
| Sumitomo Pharma America, INC. | $254.16 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $244.56 | 2021-2025 | Prolaris, Myrisk |
| Pfizer INC. | $238.43 | 2019-2025 | |
| Axonics, INC. | $234.28 | 2021-2023 | Axonics |
| Antares Pharma, INC. | $228.24 | 2020-2024 | Xyosted, Nocdurna, Tlando |
| Coloplast Corp | $208.17 | 2019-2025 | Speedicath |
| Neotract INC. | $201.18 | 2019-2020 | |
| Astellas Pharma US INC | $194.19 | 2019-2025 | Padcev |
| Abbvie INC. | $181.40 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $180.26 | 2019-2023 | Xiaflex |
| Myovant Sciences INC. | $163.72 | 2021-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $151.83 | 2022-2025 | Pylarify |
| Blue Earth Diagnostics | $151.17 | 2021-2025 | Posluma |
| Laborie Medical Technologies Corp. | $145.96 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $143.15 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Procept Biorobotics Corporation | $123.70 | 2022-2023 | Aquabeam Robotic System |
| Telix Pharmaceuticals | $118.65 | 2023-2025 | Illuccix |
| Novartis Pharmaceuticals Corporation | $110.62 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $107.70 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $97.16 | 2024-2025 | Provenge |
| 180 Medical, INC. | $81.45 | 2019-2022 | |
| Olympus America INC. | $76.13 | 2025 | Itind System |
| Ferring Pharmaceuticals INC. | $76.10 | 2019-2025 | Adstiladrin |
| Verity Pharmaceuticals INC. | $66.52 | 2022-2025 | Trelstar |
| Teleflex LLC | $66.02 | 2022-2023 | Urolift |
| Boston Scientific Corporation | $60.02 | 2021-2024 | Rezum Generator |
| Convatec INC. | $52.66 | 2021-2023 | |
| Calyxo, INC. | $50.02 | 2024-2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $45.30 | 2022-2024 | |
| Acerus Pharmaceuticals Corporation | $44.71 | 2021 | |
| Immunitybio, INC. | $42.44 | 2024-2025 | |
| Abc Home Medical Supply, INC. | $32.42 | 2023 | |
| Tolmar, INC. | $27.75 | 2023 | |
| Amgen INC. | $24.54 | 2019 | |
| Alnylam Pharmaceuticals INC. | $23.88 | 2021 | |
| Endo USA, INC. | $22.56 | 2024 | Xiaflex, Aveed |
| Dentsply Ih INC. | $21.95 | 2019 | |
| Halozyme INC | $18.80 | 2023 | |
| Travere Therapeutics, INC. | $17.52 | 2021 | |
| Photocure INC | $17.51 | 2024 | Cysview |
| Foundation Medicine, INC. | $16.74 | 2023 | |
| Allergan, INC. | $16.69 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $15.72 | 2020 | |
| Ethicon US, LLC | $14.87 | 2021 | |
| Sagent Pharmaceuticals | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.